Submitted by Anonymous (not verified) on 11 July 2024 - 14:30
EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna
Source:
EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna